INTRODUCTION:

Experimental pharmacology investigates the effects of drugs on biological systems through laboratory-based studies. It plays a central role in drug discovery and development by assessing pharmacokinetics, pharmacodynamics, toxicity, and therapeutic efficacy. Conventional methods-such as in-vivo, in-vitro, and ex-vivo models-have contributed significantly to pharmacological research but are often limited by ethical concerns, high costs, and low predictive accuracy for human outcomes^1,2.

To overcome these challenges, modern experimental pharmacology is integrating advanced techniques that offer greater precision, efficiency, and relevance. In-silico methods, including molecular docking and QSAR modeling, enable virtual simulations of drug-target interactions and predictive toxicology. High-throughput screening (HTS) facilitates rapid analysis of thousands of compounds, expediting early-stage drug discovery. Meanwhile, 3D cell cultures and organ-on-a-chip technologies replicate complex human tissue architecture and physiology, enhancing the translatability of preclinical findings^3,4.

These innovations not only reduce reliance on animal testing but also support personalized medicine, improve toxicity screening, and accelerate the development of safer and more effective therapeutics⁴. This review highlights the significance, working principles, and applications of these emerging techniques, marking a paradigm shift in experimental pharmacology.

Objectives of Experimental Pharmacology: ^5,6

The primary objective of experimental pharmacology is to systematically investigate the effects of drugs on biological systems through controlled laboratory experiments. This field is essential in understanding drug actions, mechanisms, safely and efficacy which are critical for drug discovery and development.

Role of Experimental Pharmacology in Drug Discovery and Development:

1. Identifying Drug Targets:

Helps in understanding disease mechanisms and identifying molecular targets for new drugs.

2. Screening Potential Compounds:

Evaluates chemical compounds for biological activity and therapeutic potential.

3. Mechanism of Action Study:

Investigate how the drugs interact with receptors, enzymes and cellular pathways.

4. Preclinical Testing:

Assesses pharmacokinetics (absorption, distribution, metabolism and excretion) and pharmacodynamics (drug effect and mechanism of action)

5. Toxicity Assessment:

Determines the safety profile of drugs before human trials.

6. Optimising Drug Formulations:

Helps in developing the most effective and safe dosage form.

Traditional Methods Used in the Experimental Pharmacology:^2,4

1. In-Vivo Studies (Whole Animal Studies):

While in-vivo studies are essential for understanding drug effects in a complex biological system, they come with several limitations,

· Ethical concerns:

· Species differences:

· High cost and time consuming:

· Variability in results:

· Limited mechanistic insights:

2. In-Vitro (Isolated Organ Studies):

While in-vitro Studies are valuable for the understanding drug effect at cellular or the molecular level they have several limitations,

· Lack of whole-body system interaction

· Limited predictability

· Absence of complex biological factors

· Artificial conditions

· Short term observations

· Difficulty in Studying complex diseases

· Reproducibility issues

3. Ex-Vivo (Experiment on organ and tissue):

Ex-vivo studies involve experiments conducted on organs, tissues or cells taken from a living organism and maintained in an artificial environment, they come with several limitations,

· Loss of systemic interactions

· Limited lifespan of tissues

· Artificial conditions

· Ethical and technical challenges

· Limited clinical translation.

· High cost and complexity

Importance of Newer Techniques^3,4:

New techniques in science, medicine and technology are essential for progress, improving accuracy, efficiency and expanding our understanding of complex systems. Here's why they are needed:

1. Increased Accuracy and Precision:

Older methods often have limitations in sensitivity and specificity. Newer techniques provide more precise and reliable results, reducing errors and improving reproducibility.

2. Faster and more Efficient Processes:

Advanced techniques automate and streamline processes saving time and resources. For example next generation sequencing allows rapid genetic analysis compared to traditional Sanger sequencing.

3. Ability to Study Complex Systems:

New methods enable deeper exploration of biological, chemical and physical processes.

Techniques like CRISPR, gene editing allow precise genetic modifications that were previously impossible.

4. Overcoming Limitations of Traditional Methods:

Older methods may be invasive, slow or have low resolution. For instance non-invasive imaging techniques like MRI have replaced older and riskier diagnostic procedures.

5. Personalized Medicine and Targeted Treatments:

Advanced technologies help develop personalized treatments based on individual genetics, improving healthcare outcomes.

6. Cost-Effectiveness in the Long Run:

While new techniques may be expensive initially. They often reduce long term cost by improving efficiency, reducing failures and preventing unnecessary procedures.

7. Addressing Emerging Challenges:

New challenges such as antibiotic resistance or climate change require innovative approaches. Modern biotechnology such as synthetic biology, helps to develop new antibiotics.

8. Ethical and Safer Alternatives:

Advancements like organ-on-a-chip technology reduce the need for animal testing, offering more ethical and human relevant results.

Newer Techniques used in the Experimental Pharmacology⁵:

1. In-silico techniques

2. High-Throughput Screening (HTS)

3. Organ-On-A-Chip and Microfluidic Devices

4. 3-D cell culture

1. In-silico Techniques:

In silico techniques refer to computational methods and simulations used to analyze the biological, chemical and physical process using computer models These techniques are widely used in fields like drug discovery, genomics and molecular biology⁵.

Applications of In-silico Techniques^6,7:

1. Drug Discovery and Development:

· Molecular Docking: Predicts how drugs bind to their target proteins, helping identify potential drug candidates. QSAR (Quantitative Structure-Activity Relationship) correlates chemical structure with biological activity to predict the effects of new molecules.

· Pharmacophore modelling: Identifies essential features responsible for drug activity to design better drugs. Virtual screening screens large chemical libraries to find potential drug candidates reducing time and cost in the early-stage of drug discovery.

2. Toxicity and ADME Prediction:

In-silico (ADME) modeling predicts how a drug is processed in the body. In-silico toxicology uses computational models to assess the toxicity of chemicals and drugs before animal or human testing.

3. Personalized Medicine:

Drug response prediction analyses genetic variation to predict individuals respond to specific drugs, aiding in personalized treatment. Biomarker discovery identifies genetic and molecular markers for diseases.

4. Vaccine and Antibody Design:

Epitope mapping identifies viral or bacterial components that trigger immune responses to design effective vaccines. Molecular dynamics simulations studies protein ligand interactions to improve vaccine stability and effectiveness.

5. Synthetic Biology and Enzyme Engineering:

Protein design Modifies enzymes or proteins for industrial and medical applications. Metabolic pathway modeling simulates biochemical reactions to optimize microbial production of biofuels, pharmaceuticals and other biochemicals.

6. Cancer Research and Genomics:

Molecular docking and virtual screening Identifies potential anticancer drugs by targeting specific proteins. Gene expression analysis uses machine learning to analyze large genomic datasets for cancer.

1. Molecular Docking:

Molecular docking is a computational technique used to predict how a drug binds to its biological target and to estimate the strength of this interaction known as binding affinity This technique plays a crucial role in drug discovery by helping researchers identify promising drug candidates before conducting expensive laboratory experiment⁶.

Molecular Docking Predicts Binding Affinity:

Molecular docking involves two main components: Scaring functions and Search algorithms. These components work together to predict how well a ligand fits into the binding site of a target protein⁶.

1. Search Algorithmus (Pose Prediction): ^6,7

The docking algorithm explores different ways a ligand can fit into the target binding sites. This involves;

· Generating multiple conformations of the ligand (Flexibility in shape).

· Exploring different orientations within the binding pocket.

· Evaluating interactions between the ligand and target such as hydrogen bonds, hydrophobic interactions and electrostatic forces.

2. Scoring Functions (Binding Affinity Calculation):⁷

After generating potential binding poses, scaring functions are used to estimate the binding affinity of each pose. The scaring function evaluates;

· Intermolecular forces- Strength of hydrogen band, wonder waals forces and hydrophobic interactions:

· Electrostatic interaction- The charge-based attraction or repulsion between the ligand and the target.

· Desolvation energy- The energy changes when the ligand molecules from a solvent environment into a binding packet.

· Entropy changes- The flexibility loss upon binding.

· Applications⁸:

· Drug discovery: Identifies potential drug candidates for diseases.

· Structure: Based drug design-Helps in modifying molecules for better binding.

· Electrostatic Interactions: The charge-based attraction or repulsion between the ligand and target.

· Understanding drug resistance: Analyzes how mutations affect drug binding.

· Enzyme: Inhibitor studies-finds molecules that inhibit enzyme activity.

2. Quantitative Structure Activity Relationship (QSAR):⁹

Quantitative Structure-activity relationship (QSAR) modeling is a computational technique that establishes a mathematical relationship between the chemical structure of compounds and their biological activity. It helps predict the activity of new or untested compounds based on the properties of known molecules.

QSAR modeling follows a systematic approach to analyse and correlate chemical structure with biological effects.

1. Data Collection:

Experimental biological activity data is collected for a series of known compounds. The molecular structures of these compounds are analysed.

2. Molecular Descriptor Calculation:

· Physicochemical properties- Molecular weight.

· Electronic properties- charge distribution, dipole moment, etc.

· Topological and geometric features- shape, connectivity, 3D conformations, etc.

· Hydrogen bonding potential- Donor/acceptor count.

3. Model Development:

A statistical or machine learning algorithm is used to create a mathematical model that correlates molecular descriptors with biological activity.

Common modeling techniques include:

· Linear regression- For simple linear relationships.

· Machine learning- For complex non-linear relationships.

4. Model Validation:

The model is tested using a separate dataset to check its predictive accuracy. Metrics such as R² and RMSE assess the model.

5. Prediction of New Compounds:

Once validated the QSAR model can predict the biological activity of new or untested molecules helping in drug discovery and optimization.

Application of QSAR¹⁰:

Drug discovery: identifies potential drug candidates before synthesis, Toxicology prediction: estimates toxicity of chemicals. (eg, in cosmetics or environmental pollutants), Lead optimization: helps to modify molecular structures to enhance activity or reduce side effects.

2. High-Throughput Screening (HTS): ¹¹

High-Throughput Screening (HTS) is an automated process used to rapidly test thousands to millions of chemical compounds for biological activity. It plays a crucial role in early-stage drug discovery by identifying potential drug candidates that Interact with a biological target such as a protein or enzyme.

1. Compound Library Preparation:

Diverse collection of small molecules or natural products is compiled. These compounds are stored in microplates to follow parallel testing.

2. Assay Development:

A biological assay is designed to measure a compound's effect on a target. Assays can be based on enzyme inhibition, receptor binding reliability or gene expression.

3. Robotic Screening and Automation:

Automated liquid handling systems dispense compounds into assay wells. Robots and microfluidic systems ensure rapid and precise execution.

4. Detection and Data Collection:

The biological response is measured using techniques like fluorescence luminescence (eg. detecting enzyme activity), Absorbance-based assays (eg. calorimetric changes), High-content imaging (eg. cellular response analysis)

5. Data Analysis and Hit Identification:

Collected data is analyzed to identify "hit" compounds that show promising biological activity.

6. Hit-To-Lead Optimization:

Identified hits undergo further testing to refine potency, selectivity and toxicity before advancing to lead compound development.

Applications of HTS:¹¹

1. Drug Discovery and Development:

Target based drug discovery: HTS helps identify small molecules that interact with specific biological targets such as enzymes or receptors.

Phenotypic screening: Without knowing the precise target, chemicals and entire cells or organisms are tested to see how they affect biology.

2. Toxicology and Safety Assessment:

Predicting drug toxicity: HTS screens drugs for potential toxic effects such liver toxicity or cardiotoxicity before clinical trials.

Environmental toxicology: Tests chemicals for their impact on human health and ecosystem.

Off-Target effects: Identifies unintended interactions of drugs with other proteins.

3. Personalized Medicine:

Cancer drug screening: HTS helps to match cancer patients with the most effective drug based on their tumor's genetic profile.

Patient-derived cell screening: Tests drugs on patient derived cells to find the best treatment options for individual patients

4. Vaccine and Antibody Discovery:

Identifying vaccine candidates screens virolor bacterial proteins for the immune system activation.

Monoclonal antibody discovery: HTS Helps to develop therapeutic antibodies by identifying molecules that bind to disease related target.

5. Infectious Disease Research:

Antimicrobial drug discovery: Screens compounds against bacteria, viruses and fungi to develop new antibodies.

Pandemic preparedness: Rapid screening of drug libraries against emerging pathogens.

3. Organ-On-A-Chip and Microfluidic Devices:

1. Organ-On-A-Chip:

Organ-on-a-chip (Ooc) and microfluidic devices are revolutionary technologies that mimic human organs and biological systems on a miniature scale. These lab-on-a-chip systems integrate cells, fluids and biomaterials to stimulate physiological conditions enabling better drug testing, disease modeling and personalized medicine. Organ-on-a-chip devices are microfluidic platforms that replicate the structure and function of human organs by culturing living cells in a dynamic environment¹².

Key features of OoC:¹²

· Mimics organ level physiology (eg. lung, heart, liver, brain)

· Uses microfluidics to create blood flow like conditions.

· Enables real time monitoring of cell behaviour and drug effects.

· Applications of OoC¹³:

· Drug Testing and Development: Predices human drug responses more accurately than animal models.

· Disease modeling: Helps study conditions like cancer, alzheimer's and COVID-19.

· Personalized medicine: Uses patient derived cells to tailor treatments.

· Toxicology Studies Assess the safety of chemicals and cosmetics.

2. Microfluidic Devices:^14,15

Microfluidic devices control tiny amounts of fluids in channels with dimensions of 10-100 micrometers.

Key features of microfluidic devices:

· Precise manipulation of liquids at the microscale.

· Minimal reagent consumption reducing costs.

· High throughput screening capability.

· Applications:

· More accurate than animal testing.

· Faster drug screening.

· Reduces the need for human and animal trials.

· Cost-effective and scalable.

Liver-On-A-Chip Studying Drug Metabolism and Hepatotoxicity:

Hepatocytes (liver cells) are cultured inside a microfluidic chip to mimic the 3-D Liver microenvironment. Microfluidic channels allow the flow of nutrients, oxygen and drugs, simulating blood circulation. Liver specific functions such as drug metabolism, detoxification and bile production are monitored.

Applications:

1. Drug Metabolism Studies:

Tests how drugs are broken down in the liver and transformed into active/inactive metabolites. Helps determine dosage, half-life, and bioavailability of new drugs.

2. Hepatotoxicity Screening:

Detects liver damage caused by drugs before human trials. Prevents toxic drugs (e.g. acetaminophen overdose, drug induced liver injury).

3. Disease Modeling:

Models in liver diseases like fatty liver diseases, hepatitis and cirrhosis.

4. Personalized Medicine:

Uses patient-derived liver cells to test drug responses for customized treatments. Heart-on-A-Chip studying cardiotoxicity and heart function.

Cardiomyocytes (heart muscle cells) are grown on a flexible microfluidic chíp. The chip mimics blood flow, electrical impulses and mechanical contractions of the heart. Sensors track heartbeat-like contractions, electrophysiology and drug responses in real time.

4. 3-D Cell Culture:¹⁶

3-D cell culture is a technique used in biological research where cells are grown in a three-dimensional environment instead of traditional two-dimensional monolayers and flat surfaces. This method better mimics the natural conditions found in living organisms allowing for more physiologically relevant studies of cell behaviour, drug responses, and disease mechanisms.

Key Feature of 3-D Cell Culture:

1. Structural Complexity:

Cells grow in multiple layers, forming tissue like structures.

1. Improved Cell-Cell Matrix Interactions:

More accurately represents the microenvironment found in-vivo.

2. Enhanced Cellular Functions:

Cells exhibit more natural morphology, generate expression and function.

Applications:

· Cancer research.

· Drug Screening and toxicity testing

· Tissue engineering and regenerative medicine

· Disease modeling

3-D cell cultures more accurately represent tissue architecture because they replicate the spatial organization, cell-cell interaction and extracellular matrix environment found in living tissues.

1. Spatial Organization and Cell Morphology:

In 2-D cultures cells grow in a flat monolayer structure which limits their ability to interact in a natural way. In 3-D cultures cells can organize into spheroids. Organoids or tissue-like structures allow them to adapt shapes and orientations similar to in-vivo tissues.

2. Cell-Geu Interactions:

In tissues cells communicate through direct cell-to-cell contacts and various signaling pathways. 3-D cultures allow cells to maintain polarization differentiation and multi-layered structures which are essential for tissue-specific functions.

3. Extracellular Matrix (EcM) Mimicry:

The EcM provides structural support for biochemical signals and mechanical cues for cell growth and function. 3-D cultures often use hydrogels, scaffolds or bioprinted structures that mimic the EcM allowing cells to attach, migrate and interact with their surroundings in a tissue-like manner.

4. Tissue-Specific Functional Behavior:

Cells in 3-D environments exhibit realistic gene expression, protein production and drug response similar to in-vivo conditions. This is particularly useful in cancer research, where tumors behave differently in 20 us 30 cultures.

5. Formation of Tissue-Like Microenvironments:

3-D models support gradients of oxygen, nutrients and signaling molecules, similar to real tissues. This allows for more accurate modeling of physiological and pathological conditions such as hypoxia in tumors or stem cell niches.

Some New Emerging Technologies in Drug Discovery:

1. Spheroid Culture in Cancer Research for Drug Testing:^17,18

Spheroid cultures are 3-D cell culture models where cancer cells aggregate into spherical structures, closely mimicking the tumour microenvironment found in-vivo. These models are widely used in cancer research and drug testing because they better represent how tumors grow, interact with their surroundings and respond to treatments.

Importance:

1. Tumor Like Architecture:

· Cells in spheroids self-organize into layers, mimicking the structural complexity of tumors. Outer layer: Proliferating cells exposed to nutrients and oxygen.

· Middle layer: Quiescent (Dormant) cells with limited nutrient access.

· Core: Hypoxic and necrotic regions similar to large tumors in-vivo.

2. Better Cell-Cell and Cell-ECM Interactions:

In spheroids cancer cells communicate via direct cell-cell interactions and secrete their own extracellular matrix. This enhances the realistic response to drugs as tumar cells are often protected by their surroundings.

3. Drug Penetration and Resistance Studies:

Traditional 2-D cultures often overestimate drug efficacy because drugs easily reach all cells.

In spheroids drugs must penetrate multiple layers, mimicking real tumors, where drug diffusion is often limited.

4. Hypoxia And Metabolic Gradients:

Tumors develop oxygen and nutrient gradient leading to hypoxia-induced drug resistance.

Spheroids naturally replicate these gradients, making them ideal for testing hypoxia-targeted therapies.

Application of Spheroid Based Drug Testing:

· Personalized Cancer Therapy:

· Testing potient derived concer cells in spheroid models to predict with drugs will work best foron individual.

· Immunotherapy Studies:

· Evaluating how immune cells such as T cells or NK cells, infiltrate tumors and attack cancer cells.

· Radiation Sensitivity Testing:

· Understanding how tumers respond to radiation therapy in 3-D environment.

· Anti-Metastatic Drug Screening:

· Studying how cancer cells invade surrounding tissues and testing drugs that prevent the metastasis

2. Organoids:^19,20

Organoids are miniature self-organizing 3-D cell cultures derived from stem cells or patient tissues that closely mimic the structure and function of real organs. Unlike spheroids which are simple cell aggregates organoids develop complex tissue like architectures with multiple cell type making them highly valuable for studying organ function, disease mechanisms and long-term drug effects.

Importance:

1. More Accurate Organ Mimicry:

Organoids develop functional structures resembling real tissues, including multiple cell layers and organ specific features.

Examples:

Brain organoids form neurons and glial cells mimicking brain development.

Liver organoids can perform detoxification like real liver tissue.

2. Long-Term Drug Testing:

Unlike 2-D cultures which may survive only a few days organoids can be maintained for weeks or months allowing researches to study.

Chronic drug effects (eg. long term toxicity, cumulative side effects).

Drug metabolism (eg. how the liver breaks down drugs over time).

Delayed responses (eg. cancer resistance developing after prolonged drug exposure).

3. Personalized Medicine:

Organoids can be derived from patient biopsy sample to test how an individual cells respond to different treatments. (eg. Tumor organoids from a cancer patient can be used to identify the most effective, chemotherapy before starting treatment.)

4. Disease Modeling:

Organaide can replicate genetic diseases, infection and degenerative conditions. Examples: cystic fibrosis-lung organoids are used to test CFTR-modulating drugs.

Neurodegenrative diseases: Brain organoids help in studying alzheimer's and parkinson's disease.

Infectious diseases: organoids have been used to study how viruses infest lung and intestinal tissues.

5. Toxicity Screening and Drug Safety:

Organaids allow for testing off-target effect and toxicity before drugs enter clinical triais. Example-kidney organoids can help assess whether drugs couse nephrotoxicity (kidney damage).

CONCLUSION:

The integration of advanced technologies in experimental pharmacology has significantly enhanced the accuracy, efficiency, and ethical standards of drug discovery and development. Techniques such as in-silico modeling, HTS, 3-D cell cultures, and organ-on-a-chip systems offer more physiologically appropriate models that closely resemble the human biological responses. These methods overcome many limitations of traditional approaches, enabling better prediction of drug efficacy, toxicity, and personalized therapeutic responses. As the pharmaceutical industry moves toward precision medicine, adopting these innovative tools is essential for reducing drug development costs, minimizing animal use, and improving translational outcomes. Continued advancement and integration of these techniques will undoubtedly shape the future of experimental pharmacology, offering safer, faster, and more targeted therapeutic solutions.

ACKNOWLEDGEMENT:

We want to express our sincere gratitude to everyone who assisted us in completing this study. We are also appreciative of the college's opportunity and assistance in allowing us to participate in and contribute to this review article.

DECLARATION OF CONFLICTING INTEREST:

Conflicts of interest are not present concerning the review work conducted by the authors.

REFERENCE:

1. Balagopalan D, Hussain G, Nidhin MM, Nambiar S, A review on experimental pharmacology, Journal of Drug Delivery and Therapeutics. 2019; 9(1-s): 501-504. DOI: http://dx.doi.org/10.22270/jddt.v9i1-s.2242.

2. Kashish R. Mulani, B.P. Chaudhari, V. K. Redasani, Kalyani Gardi. Drug Discovery and Development. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(2): 185-0.

3. Dibyajyoti Saha, Mayukh Jana, Supradip Mandal. Target Discovery and Validation: Advances in Molecular Pharmacology. Asian J. Pharm. Ana. 2011; 1(2): 27-28.

4. Shoaib Ahmad. Recent advances in Pharmacology and Toxicology of Phytopharmaceuticals. Asian J. Pharm. Res. 2017; 7(4): 222-224.

5. Chikhale H U. Review on In-silico techniques: An approach to Drug discovery. Current Trends in Pharmacy and Pharmaceutical Chemistry. 2020; 2(1): 24-32.

6. Shalini A. Shinde, Manasi J. Mhetar, Avantika G. Parit, Akash R. Thombre. In-silico Investigation and ADMET Prediction of Potential Antifungal Phytochemicals against Lanosterol 14-Alpha Demethylase Inhibitors. Asian Journal of Pharmaceutical Research. 2024; 14(1): 33-8.

7. Apeksha P. Motghare, Parimal P. Katolkar, Tina S. Lichade. In-Silico Prediction of Phytoconstituents from Phyllanthus niruri for Anticancer Activity against Prostate Cancer Targeting MRCK kinases. Research Journal of Pharmacy and Technology. 2023; 16(9): 4105-1.

8. Vishwajit S. Patil, Prithviraj A. Patil. Molecular Docking: A useful approach of Drug Discovery on the Basis of their Structure. Asian Journal of Pharmaceutical Research. 2023; 13(3): 191-5.

9. Nachiket S. Dighe, Pankaj Shinde, Harshali Anap, Sanjay Bhawar, Deepak S. Musmade. QSAR Study and Synthesis of some new 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives as Anti-microbial and Anti-inflammatory Agents. Asian J. Pharm. Res. 2014; 4(4): 174-179.

10. Sakshi Bhardwaj, Sonal Dubey. Qsar and Docking Studies of Some Novel Piperine Analogues as Monoamine Oxidase Inhibitors. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(2): 115-2.

11. Ravi Kumar. Drug Discovery (Lead Identification and High Throughput Screening). Research Journal of Pharmacology and Pharmacodynamics. 2021; 13(2): 46-0.

12. Suresh A. Marnoor. A Short Review on Organ-on-a-chip Technology. Asian Journal of Pharmacy and Technology. 2023; 13(2): 111-4.

13. Ajay I. Patel, Bhatt Isha, Amit J. Vyas, Nilesh Patel. Organ-on-a-chip and 3D printing as preclinical models for medical research and practice. International Journal of Technology. 2022; 12(1): 1-8.

14. Wu F, Zhou Y, Li L, et al. Computational Approaches in Preclinical Studies on Drug Discovery and Development. Front Chem. 2020; 8:726. doi:10.3389/fchem.2020.00726

15. Deng J, Yang Z, Ojima I, et al. Artificial Intelligence in Drug Discovery: Applications and Techniques. arXiv. 2021. Available from: https://arxiv.org/abs/2106.05386

16. Abhijit Ray. Scope of Embryonic Stem Cells in research. Asian J. Nur. Edu. and Research. 2012; 2(2): 51-54.

17. Gorgulla C. Recent Developments in Structure-Based Virtual Screening Approaches. arXiv. 2022. Available from: https://arxiv.org/abs/2211.03208

18. Hossain MK. Advancements in In-silico Toxicology Models for Drug Safety Assessment. World J Pharmacol Toxicol. 2024. Available from: https://www.omicsonline.org/open-access/advancements-in-insilico-toxicology-models-for-drug-safety-assessment-132396.html

19. Chu X, Wang Y, Tian P, et al. Advanced Sampling and Modeling in Molecular Simulations for Slow and Large-Scale Biomolecular Dynamics. Front Mol Biosci. 2021; 8:70. doi:10.3389/fmolb.2021.667157

20. Badar MS, Shamsi S, Ahmed J, Alam MA. Molecular dynamics simulations: Concept, Methods, and Applications. Springer. 2022.

Received on 23.08.2025 Revised on 01.10.2025

Accepted on 05.11.2025 Published on 13.04.2026

Available online from April 15, 2026

Asian J. Pharm. Tech. 2026; 16(2):193-200.

DOI: 10.52711/2231-5713.2026.00028

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.